SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Sep 5, 2023

2. SEC Identification Number

15552

3. BIR Tax Identification No.

000-663-983-000

4. Exact name of issuer as specified in its charter

Philippine Savings Bank

5. Province, country or other jurisdiction of incorporation

Manila, Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

PSBank Center, 777 Paseo de Roxas corner Sedeño St., Makati City Postal Code 1226

8. Issuer's telephone number, including area code

(02) 8885-8208

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares	426,859,416

11. Indicate the item numbers reported herein

Item 9 Other Events

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Philippine Savings BankPSB

PSE Disclosure Form 4-30 - Material Information/Transactions References: SRC Rule 17 (SEC Form 17-C) and
Sections 4.1 and 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Philippine Savings Bank’s Published Statement of Condition ending June 30, 2023
Background/Description of the Disclosure
Submission of Philippine Savings Bank’s Published Statement of Condition ending 30 June 2023. This will be published in a newspaper on 06 September 2023, Wednesday, as required by the Bangko Sentral ng Pilipinas.
Other Relevant Information
Please see attachment. Thank you!